|
|
Volumn 356, Issue 9240, 2000, Pages 1522-
|
|
Medical ethics [4]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CHOLESTEROL;
CREATINE KINASE;
DOLICHOL;
MEVALONIC ACID;
NON PRESCRIPTION DRUG;
STATIN;
UBIQUINONE;
CARDIOVASCULAR DISEASE;
CATARACT;
CHOLESTEROL SYNTHESIS;
DRUG COST;
DRUG EFFECT;
DRUG MARKETING;
DRUG SAFETY;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
HYPERLIPIDEMIA;
KIDNEY FAILURE;
LETTER;
LIVER TOXICITY;
MEDICAL ETHICS;
MENTAL DISEASE;
MYOPATHY;
NEOPLASM;
PLEIOTROPY;
PRIORITY JOURNAL;
RHABDOMYOLYSIS;
ADVERTIZING;
CONSUMER;
DRUG INDUSTRY;
ECONOMICS;
LEGAL ASPECT;
NOTE;
STANDARD;
UNITED KINGDOM;
UNITED STATES;
ADVERTISING;
CONSUMER PARTICIPATION;
DRUG INDUSTRY;
ETHICS, MEDICAL;
GREAT BRITAIN;
HUMANS;
UNITED STATES;
|
|
EID: 0034727251
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(05)73270-0 Document Type: Letter |
|
Times cited : (2)
|
|
References (5)
|
